Complement factor H targeting antibody (Alchemab Therapeutics)
N/A
Report date: 2023/12/07 16:28:10
Base Information
Drug NameComplement factor H targeting antibody (Alchemab Therapeutics)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlchemab Therapeutics Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAlchemab Therapeutics Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A